Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.7801 (18.02%) ($0.7801 - $0.7801) on Fri. Mar. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.64% (three month average) | RSI | 48 | Latest Price | $0.7801(18.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.4% a day on average for past five trading days. | Weekly Trend | ANPC declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) GLD(39%) UUP(39%) USO(34%) VXX(21%) SLV(19%) | Factors Impacting ANPC price | ANPC will decline at least -3.82% in a week (0% probabilities). XLB(-37%) REMX(-36%) IGOV(-33%) XLF(-32%) EWJ(-31%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.82% (StdDev 7.64%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $0.72(8.35%) | 10 Day Moving Average | $0.72(8.35%) | 20 Day Moving Average | $0.78(0.01%) | To recent high | -40.2% | To recent low | 22.9% | Market Cap | $7m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |